The Gujarat Kidney IPO opening date is December 22, 2025, and the IPO will close on December 24, 2025. The Gujarat Kidney IPO is a book-building issue. The company will raise approximately ₹250.80 crore through the IPO, which includes a fresh issue of ₹250.80 crore and an offer for sale of up to [.] equity shares with a face value of ₹2.
The Gujarat Kidney IPO price band is ₹108 to ₹114 per share. The retail quota is 10%, QIB 75%, and HNI 15%. The Gujarat Kidney IPO will be listed on the BSE and NSE on December 30, 2025. The allotment date for the Gujarat Kidney IPO is December 26, 2025.
The company reported revenue of ₹40.40 crore in 2025, compared to ₹5.48 crore in 2024. The company reported a profit of ₹9.50 crore in 2025 compared to a profit of ₹1.71 crore in 2024. According to financials, IPO investors should apply for the long term in IPOs.
About the Gujarat Kidney IPO
Gujarat Kidney and Superspeciality Limited (GKASSL), formed in 2019, is one of the leading companies providing multispecialty healthcare services. The company has several hospitals in Gujarat, India. Its main services include secondary and tertiary care services. Internal medicine, general surgery, minimally invasive procedures, orthopedics and trauma treatment, joint replacement surgery, obstetrics and gynecology, respiratory failure, non-interventional cardiology, diabetes, and anesthesiology are some of the medical care services the company provides.
The business operates seven multispecialty hospitals and four pharmacies. Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Center (Anand) are some of the hospitals operated by the company.
Gujarat Kidney & Superspeciality Limited (GKASSL), incorporated in 2019, specializes in providing multispecialty healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.
The company operates seven multispecialty hospitals and four pharmacies, with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company's hospitals include Gujarat Kidney & Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s Surya Hospital & ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Center (Anand). The company also operates Ashwini Medical Store (Anand).
Services:
Secondary care services: General and surgical treatments.
Tertiary care services: Superspeciality surgical procedures.
Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopedics and trauma treatment, joint replacement surgery, obstetrics and gynecology, respiratory failure, non-interventional cardiology, diabetes, and anesthesiology.
As of June 30, 2025, the company had 89 doctors, 332 nurses, and 338 other staff.
Competitive Strengths:
Specialization in renal sciences, with sub-superspecialties in urology
Asset-light business model with a focus on the central region of Gujarat
Ability to attract and retain skilled and experienced quality medical professionals
Track record of operating and financial performance and growth
Gujarat Kidney IPO Details
| IPO Open Date | December 22, 2025 |
| IPO Close Date | December 24, 2025 |
| Face Value | ₹2 Per Equity Share |
| IPO Price Band | ₹108 to ₹114 Per Share |
| Issue Size | Approx ₹250.80 Crores |
| Fresh Issue | Approx ₹250.80 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Gujarat Kidney IPO Market Lot
The Gujarat Kidney IPO minimum market lot is 128 shares with ₹14,592 application amount. The retail investors can apply up-to 13 lots with 1,664 shares of ₹1,89,696 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 128 | ₹14,592 |
| Retail Maximum | 13 | 1,664 | ₹1,89,696 |
| S-HNI Minimum | 14 | 1,792 | ₹2,04,288 |
| S-HNI Maximum | 68 | 8,704 | ₹9,92,256 |
| B-HNI Minimum | 69 | 8,832 | ₹10,06,848 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 75% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 10% |
Gujarat Kidney IPO Anchor Investors
| Anchor Bidding Date | December 19, 2025 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | January 25, 2026 |
| lock-in period end date 50% shares (90 Days) | March 26, 2026 |
Gujarat Kidney IPO Dates
The Gujarat Kidney IPO date is December 22 and the close date is December 24. The Gujarat Kidney IPO allotment will be finalized on December 26 and the IPO listing on December 30.
| IPO Open Date: | December 22, 2025 |
| IPO Close Date: | December 24, 2025 |
| Basis of Allotment: | December 26, 2025 |
| Refunds: | December 29, 2025 |
| Credit to Demat Account: | December 29, 2025 |
| IPO Listing Date: | December 30, 2025 |
| IPO Bidding Cut-off Time: | December 24, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 5,68,43,250 | 99.10% |
| Promoter Holding Post Issue | 7,88,43,250 | 71.45% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores |
| Proposed acquisition of Parekhs Hospital at Ahmedabad. | ₹77.00 |
| Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”. | ₹12.40 |
| Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. | ₹30.10 |
| Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. | ₹6.83 |
| Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company | ₹1.20 |
| Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. | ₹- |
| Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch | ₹10.78 |
Gujarat Kidney IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹0.00 | ₹0.01 | ₹0.01 | ₹3.87 |
| 2024 | ₹5.48 | ₹3.21 | ₹1.71 | ₹20.53 |
| 2025 | ₹40.40 | ₹27.63 | ₹9.50 | ₹55.34 |
| June 2025 | ₹15.27 | ₹7.78 | ₹5.40 | ₹61.59 |
Gujarat Kidney IPO Valuation – FY2025
Check Gujarat Kidney IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 36.61% |
| ROCE: | 37.65% |
| EBITDA Margin: | 41.12% |
| PAT Margin: | 23.61% |
| Debt to equity ratio: | 0.15 |
| Earning Per Share (EPS): | ₹1.85 (Basic) |
| Price/Earning P/E Ratio: | NA |
| Return on Net Worth (RoNW): | 36.61% |
| Net Asset Value (NAV): | ₹5.04 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Yatharth Hospital & Trauma Care Services Limited | 14.72 | 55.84 | 8.13% | 166.62 | 880.49 Cr. |
| GPT Healthcare Limited | 6.08 | 24.51 | 20.14% | 30.21 | 407.09 Cr. |
| KMC Speciality Hospitals (India) Ltd | 1.31 | 52.60 | 13.04% | 10.08 | 231.60 Cr. |
You can visit our newipo.info website for information on any IPO, stock market, gold, crypto investment, etc. Our workers diligently research all the information on this site and make it available to you.
IPO Lead Managers aka Merchant Bankers
- Nirbhay Capital Services Private Limited
Company Address
Gujarat Kidney and Super Speciality Limited
Plot No. 1, City Sarve No. 1537/A,
Jetalpur Road, Gokak Mill Compound,
Alkapuri, Vadodara – 390 020, Gujarat
Phone: +91 265 298 4800
Email: info@gujaratsuperspecialityhospital.com
Website: https://www.gujaratsuperspecialityhospital.com/
IPO Registrar
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: gujaratkidney.ipo@in.mpms.mufg.com
Website: https://linkintime.co.in/Initial_Offer/public-